Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

ClinicalTrials.gov ID: NCT07176390

Public ClinicalTrials.gov record NCT07176390. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Rheumatoid Arthritis

Study identification

NCT ID
NCT07176390
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
182 participants

Conditions and interventions

Interventions

  • Methotrexate Drug
  • Placebo Drug
  • Tulisokibart Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 7, 2025
Primary completion
Mar 7, 2027
Completion
Sep 2, 2029
Last update posted
Apr 23, 2026

2025 – 2029

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
Arizona Arthritis & Rheumatology Associates, P.C. ( Site 1018) Glendale Arizona 85306-9802 Recruiting
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Mesa ( Site 1033) Mesa Arizona 85210 Recruiting
Arthritis & Osteoporosis Medical Center - La Palma ( Site 1024) La Palma California 90623 Recruiting
Tekton Research, LLC. ( Site 1008) Fort Collins Colorado 80528 Recruiting
Sweet Hope Research Specialty, Inc ( Site 1015) Hialeah Florida 33016 Recruiting
HMD Research LLC ( Site 1016) Orlando Florida 32819 Recruiting
Greater Chicago Specialty Physicians - Orland Park ( Site 1043) Orland Park Illinois 60467 Recruiting
AA Medical Research Center ( Site 1027) Grand Blanc Michigan 48439 Recruiting
Kansas City Physician Partners ( Site 1032) Kansas City Missouri 64111 Recruiting
Physician Research Collaboration, LLC ( Site 1002) Lincoln Nebraska 68516 Recruiting
altoona center for clinical research ( Site 1005) Duncansville Pennsylvania 16635 Recruiting
Rheumatology Specialty Center ( Site 1030) Willow Grove Pennsylvania 19090 Recruiting
AARA Clinical Research - Murfreesboro Medical Clinic ( Site 1034) Murfreesboro Tennessee 37128 Recruiting
Rheumatology Associates ( Site 1026) Arlington Texas 76012 Recruiting
Epic Medical Research ( Site 1004) Red Oak Texas 75154 Recruiting
Advanced Rheumatology of Houston - Woodlands ( Site 1000) The Woodlands Texas 77382 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07176390, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07176390 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →